16

Oct2020

PMPRB Final Guidelines Delayed, PDCI Webinar Postponed

After much anticipation, the issuance of the PMPRB Guidelines has been delayed. The revised date of publication is uncertain at this time. Due to this announcement, PDCI will be postponing its webinar focused on the final guidelines originally scheduled for Tuesday, October 20, 2020. Additional information will ... Read More

14

Oct2020

PDCI Webinar: Overview of the Final PMPRB Guidelines

On Tuesday, October 20, 2020, from 10:30-12:00pm, please join PDCI Market Access for a free in-depth walk-through of the long anticipated final PMPRB guidelines. The PDCI Pricing team (Kimberly Robinson, Dylan Lamb-Palmer, Jennifer Mathews and Mevin Mathew) will present a deep dive into the technical aspects of these changes and what they mean for grandfathered ... Read More

01

Oct2020

SAVE THE DATE: PDCI Hosting Webinar on PMPRB Final Guidelines

SAVE THE DATE - PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, will be hosting a FREE webinar session relating to the long anticipated final guidelines published by the Patented Medicine Prices Review Board (PMPRB). The webinar will take place ... Read More

15

Jul2020

REMINDER: PDCI is Hosting a Webinar on the PMPRB Guidelines

PDCI PMPRB Guidelines Webinar July 22, 2020 between 10:30 am – 12:00 pmIN ADVANCE, PLEASE SUBMIT ANY QUESTIONS YOU WOULD LIKE US TO ADDRESS Please Register here.

13

Jul2020

A WEEK FULL OF NEWS AND HAPPENINGS AT PMPRB

ALERT! PMPRB WEBINAR RESCHEDULED Given all the new information this week, as well as the consultation extension, PDCI is postponing its PMPRB webinar.  Our second free webinar for industry will now be held on July 22, 2020 between 10:30 am – 12:00 ... Read More

30

Jun2020

PMPRB: Federal Court Quashes Reporting of Third-Party Discounts & Rebates, Upholds other provisions of the Amended Patented Medicines Regulations

Yesterday, the Federal Court of Canada released its decision in the judicial review challenging the validity of the Regulations Amending the Patented Medicines Regulations that were published in Canada Gazette Part II on August 21, 2019. The judgement and reasons in Innovative ... Read More

20

Jun2020

New Draft PMPRB Guidelines: A High Level Summary

As PDCI announced earlier today, the PMPRB has issued the second draft of the PMPRB Guidelines to support the implementation of Patented Medicines Regulations (Regulations) changes coming unto force on January 1, 2021.  This draft is now available for a 30-day Notice and Comment Period.  Written feedback ... Read More

19

Jun2020

Now Released: PMPRB New Draft Guidelines

The Patented Medicine Prices Review Board (PMPRB) has just released its second set of Draft Guidelines under the recently amended Patented Medicines Regulations (“Regulations”).  This launches a 30-day consultation period for stakeholders to provide written comments on the new Draft Guidelines.  Stay ... Read More

10

Jun2020

Amendment to the Patented Medicines Regulations Published in Canada Gazette II

As expected, amendments to the Patented Medicines Regulations (“Regulations”) were published in Canada Gazette II this morning.  The amendments officially change the coming into force date of the new amending Regulation to January 1, 2021.  These Regulations were originally published in Canada Gazette II on August 21, 2020 with an ... Read More

01

Jun2020

PMPRB Guidelines and Regulations Update

PMPRB Guidelines and Regulations Update As first disclosed by PDCI last week, the PMPRB Board Chair officially confirmed that the amended Patented Medicines Regulations (“Regulations”) will now come into force on January 1, 2021.  These Regulations were published in Canada Gazette II in August 2019 with ... Read More